This is especially vital as hormonal fluctuations during perimenopause may increase insulin resistance, making effective blood sugar management essential for maintaining health and vitality
GLP-1 medications, in turn, bind to GLP receptors (that may or may not be faulty) to trigger this hormone, which both tells the pancreas to release more insulin and blocks the secretion of glucagon (the hormone that raises blood sugar levels) when necessary
The most balanced approach is typically the one that layers discovery features in small, helpful stepsnever burying important account tools or masking terms behind excessive pop-ups
We explore how GLP-1 works and how it can transform your overall well-being, including your intimate life
Approval for Diabetes and Weight Management Over the past decade, three GLP-1/GIP receptor agonists liraglutide, semaglutide, and tirzepatide initially approved by the FDA for adults with type 2 diabetes, have also gained FDA approval for chronic weight management in people without diabetes, provided they meet specific criteria: a BMI of 30, or 27 with at least one weight-related condition such as hypertension, dyslipidemia, or type 2 diabetes